Boehringer Ingelheim Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Boehringer Ingelheim careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and co...
Posted: June 19, 2019, 9:02 am
Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and co...
Posted: June 19, 2019, 9:02 am
Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and co...
Posted: June 19, 2019, 9:02 am
Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and co...
Posted: June 19, 2019, 9:02 am
Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and co...
Posted: June 19, 2019, 9:02 am

Viewing page 1 of 48|Next Page

  Newsfeed | Subscribe  

Boehringer Ingelheim and the University of Dundee have highlighted the success of the PROTAC drug discovery program, and thus extended their ongoing anti-cancer alliance. The collaboration will ...
Posted: June 19, 2019, 5:40 am
Anticoagulants Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. ...
Posted: June 18, 2019, 6:58 am
Boehringer Ingelheim invested €120m ($134m) in the construction of the plant, which was begun in 2017 and was constructed in only two years through ‘fast track’ planning. This will see the plant ...
Posted: June 18, 2019, 6:18 am
of Boehringer Ingelheim Pharmaceuticals, Inc. Total U.S. sales of Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg, was approximately $158 million for the 12 months ended April 2019, ...
Posted: June 18, 2019, 3:52 am
Boehringer Ingelheim and OSE Immunotherapeutics announce that the first patient has been dosed in the first-in-human Phase 1 clinical trial evaluating BI 765063, formerly OSE-172, a first-in-class ...
Posted: June 18, 2019, 2:20 am

Viewing page 1 of 3|Next Page